GeVIR Banner

Export Results to CSV Clear Search

Genes Fold Enrichment Color Codes
  • Gene Name, Canonical Transcript - gene identifiers from gnomAD database (Build 37)
  • GeVIR % - gene rank measured in percentiles based on Gene Variation Intolerance Ranking (GeVIR) (low values indicate more variation intolerant genes, which is also true for "LOEUF %" and "VIRLoF %"). GeVIR is a method which we developed and applied on a list of 19,361 genes to sort them based on number, length and evolutionary conservation of regions without functional variants (i.e. between two missense, loss-of-function, insertion or delition variants) in gnomAD database (version 2.0.1). Only canonical transcripts were analysed.
  • LOEUF % - gene rank measured in percentiles based gnomAD loss-of-function observed/expected upper bound fraction (LOEUF) (see Figure 1). For more information about this metric, please read "Constraint" section of MacArthur Lab blog post. If you use this metric please cite gnomAD flagship paper and use most up-to-date values from gnomAD website.

    LoF observed/expected (o/e) upper Confidence Interval (CI)

    Figure 1. Screenshot of ELN gene constraint metrics from gnomAD browser

  • VIRLoF % - gene rank measured in percentiles based on both GeVIR and gnomAD LOEUF (shows the best overall performance, see Figure 2). If you use this metric please cite both GeVIR and gnomAD flagship paper.
  • GeVIR AD, LOEUF AD, VIRLoF AD, GeVIR AR, LOEUF AR, VIRLoF AR - to help users interpret gene ranks, we calculated fold enrichment of Autosomal Dominant (AD) and Autosomal Recessive (AR) genes with known molecular basis of disorder in OMIM in a range of +-5% of gene X (see Figure 2). Statistical significant fold enrichements (Fisher Exact Test p-value < 1e-5) are shown in bold in the table. For example CDK19 gene's GeVIR % is 2.37, so examined range is from 0 (2.37-5, rounded to minimal percentile) to 7.37% (2.37+5). Genes in this range are ~4 times more often (4.05 fold enrichement) associated with AD diseases and ~4 times less often (0.25 fold enrichement) associated with AR diseases. Both enrichment of AD genes and deficiency of AR genes is statistical significant. Thus GeVIR metric adds supportive evidence that CDK19 is more likely to be associated with AD than AR disease.

    Gene Percentiles AD AR Fold Enrichment

    Figure 2. Fold Enrichment of known Autosomal Dominant (AD) and Autosomal Recessive (AR) genes of each gene in the ranked lists (GeVIR, LOEUF, VIRLoF. AD genes are enriched among top ranked genes (lowest percentiles), whereas AR genes are enriched among middle ranked genes (approximetly 35-65 percentiles). Combined metric (VIRLoF, purple) shows the best perfornance, i.e. high ranked genes are more often associated with AD than AR diseases, low ranked genes are less often associated with both AD and AR diseases.
Gene Name Canonical Transcript GeVIR % LOEUF % VIRLoF % GeVIR AD LOEUF AD VIRLoF AD GeVIR AR LOEUF AR VIRLoF AR
SET ENST00000372692 1.07 4.87 1.14 4.40 3.27 4.39 0.18 0.31 0.21
ZMAT2 ENST00000274712 0.47 9.30 2.48 4.40 2.48 4.03 0.17 0.47 0.24
OTUD5 ENST00000156084 1.22 4.37 1.03 4.40 3.27 4.45 0.17 0.32 0.21
CLTC ENST00000269122 0.56 0.80 0.07 4.40 4.11 4.85 0.19 0.27 0.15
UBE2A ENST00000371558 0.36 28.35 11.95 4.40 1.16 2.28 0.16 1.22 0.46
NRBP1 ENST00000233557 1.11 2.36 0.46 4.40 3.63 4.73 0.18 0.29 0.17
AP2M1 ENST00000292807 0.50 5.23 1.07 4.40 3.15 4.42 0.18 0.32 0.21
SIAH1 ENST00000356721 0.44 24.04 9.75 4.39 1.38 2.26 0.17 0.96 0.40
CASK ENST00000378166 1.19 0.42 0.09 4.39 4.13 4.87 0.17 0.28 0.16
FRG1B ENST00000278882 1.14 52.31 24.76 4.39 0.62 1.04 0.17 1.83 1.10
PRPF8 ENST00000572621 0.39 4.39 0.81 4.39 3.26 4.54 0.16 0.32 0.21
C6orf106 ENST00000374023 1.28 13.08 4.46 4.39 2.06 3.71 0.17 0.59 0.25
BTBD10 ENST00000278174 0.53 32.68 14.32 4.39 0.85 2.00 0.19 1.45 0.60
EEF1A2 ENST00000217182 1.08 4.81 1.12 4.39 3.29 4.41 0.18 0.32 0.21
STAT3 ENST00000264657 1.22 0.95 0.20 4.39 4.08 4.87 0.17 0.29 0.18
NKAP ENST00000371410 0.48 4.04 0.75 4.39 3.25 4.58 0.17 0.32 0.20
DDX46 ENST00000354283 1.17 3.18 0.67 4.39 3.47 4.62 0.17 0.28 0.20
CREBL2 ENST00000228865 1.11 28.19 12.23 4.39 1.18 2.26 0.18 1.21 0.50
PIK3CA ENST00000263967 0.56 1.81 0.23 4.39 3.79 4.84 0.19 0.26 0.18
RAB10 ENST00000264710 1.05 10.18 3.06 4.39 2.32 3.94 0.18 0.49 0.23
KCNB1 ENST00000371741 0.51 2.33 0.31 4.39 3.63 4.84 0.18 0.29 0.18
PABPN1 ENST00000216727 1.20 28.38 12.37 4.39 1.16 2.23 0.17 1.22 0.50
AP2S1 ENST00000263270 1.00 24.87 10.50 4.39 1.33 2.18 0.18 1.05 0.43
HMGA1 ENST00000447654 0.45 26.14 10.92 4.39 1.19 2.21 0.17 1.08 0.44
XPO1 ENST00000401558 1.14 0.12 0.05 4.39 4.10 4.87 0.17 0.28 0.15

Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.